Company: NEOG
Filing Date: 2025-09-12
Form Type: DEF 14A
Source: 0000950170-25-114381
Chunk: 10

Company: NEOGEN CORP
Filing Date: 2025-09-12
Form: DEF 14A
Chunk 10
---
 2025 Annual Meeting. Dr. Boehm served on Neogen’s Board since 2011. The Board would like to thank Mr. Tobin and Dr. Boehm for their significant contributions during their service as members of the Board. On August 14, 2025, the Board appointed Avi Pelossof to the Board, effective October 24, 2025, to fill the vacancy left with Dr. Boehm’s retirement. Mr. Pelossof was appointed as a Class II director to hold a term expiring at the 2028 annual meeting of shareholders.

| Neogen Corporation | 2025 Proxy Statement | 5 |

#### Proposal 1: Election of Directors
Information Regarding Nominees and Directors The following table sets forth the names, ages, membership on Board committees and certain other information for each of the nominees for election to the Board and each of the other members of our Board whose terms on the Board will continue after the Annual Meeting.

| Name of Director or Nominee         |     | Age |     | Position      |     | Director 
    Since |
| Mikhael Nassif                      |     |  49 |     | CEO, Director |     |     2025 |
| Thierry L. Bernard (1) (4)          |     |  60 |     | Director      |     |     2024 |
| James C. Borel (3) (4)              |     |  69 |     | Board Chair   |     |     2016 |
| Jeffrey D. Capello (1) (3)          |     |  60 |     | Director      |     |     2022 |
| Ronald D. Green, Ph.D. (2*) (4)     |     |  64 |     | Director      |     |     2014 |
| Aashima Gupta (2) (4)               |     |  54 |     | Director      |     |     2022 |
| Avi Pelossof (5)                    |     |  62 |     | Nominee       |     |       -5 |
| Raphael A. Rodriguez (1) (2)        |     |  57 |     | Director      |     |     2020 |
| Andrea F. Wainer (2) (3)            |     |  57 |     | Director      |     |     2025 |
| Catherine